Thyroid Cancer | Topics

Study Identifies Effectiveness of RNA, DNA-RNA Tests for Diagnosis of Indeterminate Thyroid Nodules
December 29, 2020

“Although previous trials demonstrated that the prior version of the DNA-RNA test was more specific than the prior version of the RNA test, the current molecular test techniques have no statistically significant difference in performance,” wrote Masha J. Livhits, MD, and colleagues.

FDA Approves Pralsetinib to Treat RET-Altered Thyroid Cancers
December 01, 2020

The FDA granted accelerated approval to pralsetinib to treat with advanced or metastatic RET-mutant medullary thyroid cancer or RET fusion-positive thyroid cancer.

FDA Approves Selpercatinib for 3 RET-Positive Cancer Types
May 08, 2020

The FDA approved the first therapy to treat cancers with rearranged during transfection (RET) gene alterations.